BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30674359)

  • 1. Can psychological features predict antidepressant response to rTMS? A Discovery-Replication approach.
    Krepel N; Rush AJ; Iseger TA; Sack AT; Arns M
    Psychol Med; 2020 Jan; 50(2):264-272. PubMed ID: 30674359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].
    Dumas R; Boyer L; Richieri R; Guedj E; Auquier P; Lançon C
    Encephale; 2014 Feb; 40(1):74-80. PubMed ID: 24091070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Repetitive Transcranial Magnetic Stimulation Treatment With Subgenual Cingulate Hyperactivity in Patients With Major Depressive Disorder: A Secondary Analysis of a Randomized Clinical Trial.
    Hadas I; Sun Y; Lioumis P; Zomorrodi R; Jones B; Voineskos D; Downar J; Fitzgerald PB; Blumberger DM; Daskalakis ZJ
    JAMA Netw Open; 2019 Jun; 2(6):e195578. PubMed ID: 31167023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy, Safety and Tolerability of Augmentative rTMS in Treatment of Major Depressive Disorder (MDD): A Prospective Cohort Study in Croatia.
    Filipcic I; Milovac Z; Sucic S; Gajsak T; Filipcic IS; Ivezic E; Aljinovic V; Orgulan I; Penic SZ; Bajic Z
    Psychiatr Danub; 2017 Mar; 29(1):31-38. PubMed ID: 28291972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prefrontal cortical blood flow predicts response of depression to rTMS.
    Weiduschat N; Dubin MJ
    J Affect Disord; 2013 Sep; 150(2):699-702. PubMed ID: 23707032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and acceptability of accelerated repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depressive disorder: an open label trial.
    McGirr A; Van den Eynde F; Tovar-Perdomo S; Fleck MP; Berlim MT
    J Affect Disord; 2015 Mar; 173():216-20. PubMed ID: 25462419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of unilateral and bilateral prefrontal cortex transcranial magnetic stimulation in treatment-resistant major depression.
    Fitzgerald PB; Hoy K; Gunewardene R; Slack C; Ibrahim S; Bailey M; Daskalakis ZJ
    Psychol Med; 2011 Jun; 41(6):1187-96. PubMed ID: 20925972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study.
    Bares M; Kopecek M; Novak T; Stopkova P; Sos P; Kozeny J; Brunovsky M; Höschl C
    J Affect Disord; 2009 Nov; 118(1-3):94-100. PubMed ID: 19249105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of response to repetitive transcranial magnetic stimulation (rTMS) in major depression: replication study in drug-free patients.
    Brakemeier EL; Wilbertz G; Rodax S; Danker-Hopfe H; Zinka B; Zwanzger P; Grossheinrich N; Várkuti B; Rupprecht R; Bajbouj M; Padberg F
    J Affect Disord; 2008 May; 108(1-2):59-70. PubMed ID: 17963846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personality dimensions and deep repetitive transcranial magnetic stimulation (DTMS) for treatment-resistant depression: a pilot trial on five-factor prediction of antidepressant response.
    McGirr A; Van den Eynde F; Chachamovich E; Fleck MP; Berlim MT
    Neurosci Lett; 2014 Mar; 563():144-8. PubMed ID: 24486892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain SPECT guided repetitive transcranial magnetic stimulation (rTMS) in treatment resistant major depressive disorder.
    Jha S; Chadda RK; Kumar N; Bal CS
    Asian J Psychiatr; 2016 Jun; 21():1-6. PubMed ID: 27208445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of intermittent Theta Burst Stimulation (iTBS) and 10-Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) in treatment-resistant unipolar depression: study protocol for a randomised controlled trial.
    Bulteau S; Sébille V; Fayet G; Thomas-Ollivier V; Deschamps T; Bonnin-Rivalland A; Laforgue E; Pichot A; Valrivière P; Auffray-Calvier E; Fortin J; Péréon Y; Vanelle JM; Sauvaget A
    Trials; 2017 Jan; 18(1):17. PubMed ID: 28086851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of motor cortex excitability predicts antidepressant response to prefrontal cortex repetitive transcranial magnetic stimulation.
    Oliveira-Maia AJ; Press D; Pascual-Leone A
    Brain Stimul; 2017; 10(4):787-794. PubMed ID: 28438543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognitive Effects of Repetitive Transcranial Magnetic Stimulation With a 2-Coil Device in Treatment-Resistant Major Depressive Disorder.
    Kavanaugh BC; Aaronson ST; Clarke GN; Holtzheimer PE; Johnson CW; McDonald WM; Schneider MB; Carpenter LL
    J ECT; 2018 Dec; 34(4):258-265. PubMed ID: 29613944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parieto-temporal alpha EEG band power at baseline as a predictor of antidepressant treatment response with repetitive Transcranial Magnetic Stimulation: a preliminary study.
    Micoulaud-Franchi JA; Richieri R; Cermolacce M; Loundou A; Lancon C; Vion-Dury J
    J Affect Disord; 2012 Mar; 137(1-3):156-60. PubMed ID: 22244378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. rTMS for pharmacoresistant major depression in the clinical setting of a psychiatric hospital: effectiveness and effects of age.
    Ciobanu C; Girard M; Marin B; Labrunie A; Malauzat D
    J Affect Disord; 2013 Sep; 150(2):677-81. PubMed ID: 23673085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actigraphy in Patients With Major Depressive Disorder Undergoing Repetitive Transcranial Magnetic Stimulation: An Open Label Pilot Study.
    Nishida M; Kikuchi S; Nisijima K; Suda S
    J ECT; 2017 Mar; 33(1):36-42. PubMed ID: 27611301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between individual alpha peak frequency and clinical outcome with repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder (MDD).
    Corlier J; Carpenter LL; Wilson AC; Tirrell E; Gobin AP; Kavanaugh B; Leuchter AF
    Brain Stimul; 2019; 12(6):1572-1578. PubMed ID: 31378603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anhedonia and reward-circuit connectivity distinguish nonresponders from responders to dorsomedial prefrontal repetitive transcranial magnetic stimulation in major depression.
    Downar J; Geraci J; Salomons TV; Dunlop K; Wheeler S; McAndrews MP; Bakker N; Blumberger DM; Daskalakis ZJ; Kennedy SH; Flint AJ; Giacobbe P
    Biol Psychiatry; 2014 Aug; 76(3):176-85. PubMed ID: 24388670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Accelerated HF-rTMS on the Subgenual Anterior Cingulate Cortex in Refractory Unipolar Major Depression: Insights From 18FDG PET Brain Imaging.
    Baeken C; Marinazzo D; Everaert H; Wu GR; Van Hove C; Audenaert K; Goethals I; De Vos F; Peremans K; De Raedt R
    Brain Stimul; 2015; 8(4):808-15. PubMed ID: 25744500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.